(L-R) Mr Dilip Patil, business unit head, CardioMetabolic Care, Merck Serono India; Mr Jitendra Awhad, Honorable Minister of Medical Education & Horticulture, Government of Maharashtra; Ms Rasha Kelej, VP, head, global business responsibility & market development, Merck Serono
The Merck Capacity Advancement Program (CAP) seeks to improve the healthcare sector in India with special focus on rural areas through educating and empowering those affected by diabetes on how to manage and prevent it.
In addition to medical education and community awareness, Merck shall continue to work with partners in India at large to expand the capacity of professionals in diabetes management through its Capacity Advancement Program.
Merck launched its Capacity Advancement Program (CAP) in India in collaboration with the Maharashtra University of Health Sciences and Directorate of Medical Education and Research, Mumbai.
The program is a part of Merck's long term commitment to provide sustainable access to high-quality health solutions and safe medicines in India and the rest of Asia.
The 5-year program kicked-off in 7 Sub-Saharan countries including Kenya, Uganda, Namibia Angola, Ghana, Tanzania, and Mozambique and will further expand to other Sub-Saharan and Asian countries in 2014.
As part of the Merck CAP, more than 1,000 medical students from the Maharashtra University of Health sciences will benefit from European-accredited clinical diabetes and chronic diseases management training, which is seeking to equip them with skills to avert the diabetes epidemic.